Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives

M Humbert, C Guignabert, S Bonnet… - European …, 2019 - Eur Respiratory Soc
Clinical and translational research has played a major role in advancing our understanding
of pulmonary hypertension (PH), including pulmonary arterial hypertension and other forms …

[HTML][HTML] Human iPSC banking: barriers and opportunities

CY Huang, CL Liu, CY Ting, YT Chiu… - Journal of biomedical …, 2019 - Springer
The introduction of induced pluripotent stem cells (iPSCs) has opened up the potential for
personalized cell therapies and ushered in new opportunities for regenerative medicine …

Patient and disease–specific induced pluripotent stem cells for discovery of personalized cardiovascular drugs and therapeutics

DT Paik, M Chandy, JC Wu - Pharmacological reviews, 2020 - ASPET
Human induced pluripotent stem cells (iPSCs) have emerged as an effective platform for
regenerative therapy, disease modeling, and drug discovery. iPSCs allow for the production …

PPARγ-p53-mediated vasculoregenerative program to reverse pulmonary hypertension

JK Hennigs, A Cao, CG Li, M Shi, J Mienert… - Circulation …, 2021 - Am Heart Assoc
Rationale: In pulmonary arterial hypertension (PAH), endothelial dysfunction and obliterative
vascular disease are associated with DNA damage and impaired signaling of BMPR2 (bone …

Differentiation, evaluation, and application of human induced pluripotent stem cell–derived endothelial cells

Y Lin, CH Gil, MC Yoder - Arteriosclerosis, thrombosis, and …, 2017 - Am Heart Assoc
The emergence of induced pluripotent stem cell (iPSC) technology paves the way to
generate large numbers of patient-specific endothelial cells (ECs) that can be potentially …

[HTML][HTML] Remodeling of active endothelial enhancers is associated with aberrant gene-regulatory networks in pulmonary arterial hypertension

A Reyes-Palomares, M Gu, F Grubert, I Berest… - Nature …, 2020 - nature.com
Environmental and epigenetic factors often play an important role in polygenic disorders.
However, how such factors affect disease-specific tissues at the molecular level remains to …

[HTML][HTML] Intrinsic endocardial defects contribute to hypoplastic left heart syndrome

Y Miao, L Tian, M Martin, SL Paige, FX Galdos, J Li… - Cell stem cell, 2020 - cell.com
Hypoplastic left heart syndrome (HLHS) is a complex congenital heart disease characterized
by abnormalities in the left ventricle, associated valves, and ascending aorta. Studies have …

[HTML][HTML] PPARγ interaction with UBR5/ATMIN promotes DNA repair to maintain endothelial homeostasis

CG Li, C Mahon, NM Sweeney, E Verschueren… - Cell reports, 2019 - cell.com
Using proteomic approaches, we uncovered a DNA damage response (DDR) function for
peroxisome proliferator activated receptor γ (PPARγ) through its interaction with the DNA …

[HTML][HTML] RNA-binding proteins: Emerging therapeutics for vascular dysfunction

VA Cornelius, H Naderi-Meshkin, S Kelaini, A Margariti - Cells, 2022 - mdpi.com
Vascular diseases account for a significant number of deaths worldwide, with cardiovascular
diseases remaining the leading cause of mortality. This ongoing, ever-increasing burden …

Advanced in vitro lung models for drug and toxicity screening: the promising role of induced pluripotent stem cells

A Moreira, M Müller, PF Costa, Y Kohl - Advanced Biology, 2022 - Wiley Online Library
The substantial socioeconomic burden of lung diseases, recently highlighted by the
disastrous impact of the coronavirus disease 2019 (COVID‐19) pandemic, accentuates the …